A 2023 ocva.eu study reveals frozen konjac glucomannan reduces visceral fat by 18% and improves insulin sensitivity in obese mice, outperforming sol and gel forms through enhanced prebiotic effects. R...
New research reveals how time-restricted eating improves metabolic health through gut microbiome modulation, with clinical benefits for diabetes and obesity management. Emerging science demonstrates T...
New research reveals konjac glucomannan’s unique ability to modulate gut microbiota and improve metabolic markers through different intake forms, offering novel obesity management strategies. Cu...
New research reveals KGM sol reduces insulin resistance 40% and boosts GLP-1 2.1-fold in obese mice, with emerging clinical evidence supporting human applications. Groundbreaking mouse studies demonst...
Recent studies demonstrate konjac glucomannan’s effectiveness in improving glucose and lipid metabolism, with novel gel forms showing enhanced benefits for obese individuals. Emerging research r...
Emerging research validates Ayurvedic approaches for diabetes and hypertension, with modern studies confirming the efficacy of herbs like Ashwagandha and Gudmar in metabolic regulation. Modern researc...
New research reveals intermittent KGM dosing improves lipid metabolism and insulin sensitivity more effectively than daily intake, with promising implications for human dietary strategies. Breakthroug...
Recent studies demonstrate konjac glucomannan’s dose-dependent effects on metabolic health, gut microbiota diversity, and appetite control in obese mice, with implications for human dietary stra...
New research reveals konjac glucomannan’s frozen gel form significantly boosts SCFA production and gut microbiota diversity in obese mice, offering promising implications for human diabetes mana...
New research reveals konjac glucomannan sol (KS) significantly improves glucose control and gut health, offering a promising dietary intervention for metabolic disorders. Cutting-edge studies demonstr...
